↓ Skip to main content

Exosomes in Cardiovascular Diseases

Overview of attention for book
Cover of 'Exosomes in Cardiovascular Diseases'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 The Multifaceted Functions of Exosomes in Health and Disease: An Overview
  3. Altmetric Badge
    Chapter 2 Exosomes: Nanocarriers of Biological Messages
  4. Altmetric Badge
    Chapter 3 Functional Role of Cardiovascular Exosomes in Myocardial Injury and Atherosclerosis
  5. Altmetric Badge
    Chapter 4 Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases
  6. Altmetric Badge
    Chapter 5 Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases
  7. Altmetric Badge
    Chapter 6 Exosomes as New Intercellular Mediators in Development and Therapeutics of Cardiomyocyte Hypertrophy
  8. Altmetric Badge
    Chapter 7 Dual Behavior of Exosomes in Septic Cardiomyopathy
  9. Altmetric Badge
    Chapter 8 Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy
  10. Altmetric Badge
    Chapter 9 Peripartum Cardiomyopathy: Do Exosomes Play a Role?
  11. Altmetric Badge
    Chapter 10 Vascular Calcification Regulation by Exosomes in the Vascular Wall
  12. Altmetric Badge
    Chapter 11 Cardioprotective Effects of Exosomes and Their Potential Therapeutic Use
  13. Altmetric Badge
    Chapter 12 Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Disease
  14. Altmetric Badge
    Chapter 13 Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases
  15. Altmetric Badge
    Chapter 14 Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair
  16. Altmetric Badge
    Chapter 15 Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease
  17. Altmetric Badge
    Chapter 16 Cardiac Telocyte-Derived Exosomes and Their Possible Implications in Cardiovascular Pathophysiology
  18. Altmetric Badge
    Chapter 17 Circulating Exosomes in Cardiovascular Diseases
  19. Altmetric Badge
    Chapter 18 Therapeutic Effects of Ischemic-Preconditioned Exosomes in Cardiovascular Diseases
  20. Altmetric Badge
    Chapter 19 Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy
Attention for Chapter 15: Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease
Chapter number 15
Book title
Exosomes in Cardiovascular Diseases
Published in
Advances in experimental medicine and biology, January 2017
DOI 10.1007/978-981-10-4397-0_15
Pubmed ID
Book ISBNs
978-9-81-104396-3, 978-9-81-104397-0
Authors

Jana Radosinska, Monika Bartekova

Abstract

As other stem cells, hematopoietic stem cells (HSCs) are able to produce extracellular vesicles (EVs) including exosomes and microvesicles. This chapter summarizes the knowledge about the production of EVs by the HSCs, their role in the intercellular communication, and will discuss the cargo of these EVs as well as protective effects of HSCs-derived exosomes and microvesicles in cardiovascular diseases (CVD). Available data showed that cardioprotective action of injected HSCs could not be explained by direct transdifferentiationof injected cells into the cardiomyocytes, this effect is suggested to be mediated via paracrine communication (by EVs) between donor and recipient cells. Among the cargo molecules of HSCs-derived vesicles several miRNAs, and pro-angiogenic and anti-apoptotic proteins are proposed to be the mediators of heart regeneration, mostly via neovascularization. However, the direct evidence of cardioprotective effects of HSCs-derived exosomes and microvesicles is still lacking in the literature. On the other hand, EVs produced in HSCs-derived cells, specifically dendritic cells and endothelial progenitor cells, have been shown to provide direct cardioprotective effects in CVD. Anyway, further studies are needed to be performed to assess the therapeutic potential of HSCs-derived EVs-based cardiac regenerative therapies.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 18%
Student > Doctoral Student 7 18%
Researcher 5 13%
Student > Bachelor 4 10%
Professor 2 5%
Other 4 10%
Unknown 10 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 28%
Medicine and Dentistry 10 26%
Engineering 3 8%
Nursing and Health Professions 2 5%
Agricultural and Biological Sciences 1 3%
Other 1 3%
Unknown 11 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2018.
All research outputs
#14,955,443
of 23,003,906 outputs
Outputs from Advances in experimental medicine and biology
#2,272
of 4,961 outputs
Outputs of similar age
#243,413
of 421,219 outputs
Outputs of similar age from Advances in experimental medicine and biology
#209
of 490 outputs
Altmetric has tracked 23,003,906 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,961 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,219 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 490 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.